Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 71
Filter
1.
Journal of Immunology ; 208(1), 2022.
Article in English | Web of Science | ID: covidwho-2201456
2.
Studies in Psychology ; 43(3):609-638, 2022.
Article in Spanish | Web of Science | ID: covidwho-2186900

ABSTRACT

The health conditions generated by the COVID-19 pandemic severely restricted in-person therapy, and as a result online therapy was put into practice. The objective of this study was to describe and analyse, from the perspective of the therapist, how the pandemic has influenced their experience and clinical practice. Qualitative interviews were conducted with 24 Latin American therapists who had performed online therapy during the pandemic. The information was analysed following the coding procedures of the Grounded Theory. Three core categories were constructed from the analysis: (a) impact on the therapist: spiral of uncertainty, oppression and adaptive astonishment;(b) incorporation of technologies into clinical practice: 'I never thought they could help';and (c) transformation of the practice of psychotherapy: 'water always finds its way'. The model incorporates and relates therapists' perceptions of their professional work, patients' attitudes towards this new psychotherapy method, perception of the therapeutic relationship and process, and the facilitators and obstacles experienced in online therapy.

3.
Hepatology ; 76(Supplement 1):S336-S337, 2022.
Article in English | EMBASE | ID: covidwho-2157779

ABSTRACT

Background: Screening for HCV is the first critical decision point for preventing morbidity and mortality from HCV cirrhosis and hepatocellular carcinoma, and will ultimately contribute to global elimination of a curable disease. This study aims to portray the changes over time in HCV screening rates and the screened population characteristics following the 2020 implementation of an EHR alert for universal screening in the outpatient setting in a large healthcare system in the US mid-Atlantic region. Method(s): Data was ed from the EHR on all outpatients from 1/1/2017 through 10/31/2021, including individual demographics and their HCV antibody screening dates. Mixed effects multivariable regression analyses were performed to compare the timeline and characteristics of those screened and un-screened for a limited period from 1/1/2020 to 10/31/2020 and centered on the EHR alert implementation. Result(s): Absolute number of screens increased by 103% after the implementation of the EHR alert. When comparing the five-month period before and after the EHR alert, the odds of being screened at an outpatient visit increased by 62% from 17 to 27 screens per 1,000 outpatient visits. Also during this time period, patients with Medicaid were more likely to be screened than private insurance (ORadj 1.10, [CI95: 1.05, 1.15]), females more likely than males (1.26, [1.20, 1.32]);Black race more than White (1.59, [1.53, 1.64]);while those with Medicare were less likely than private insurance (0.62, [0.62, 0.65]). Over the entire 58-month period, the HCV Ab positivity rate decreased from 4.2% to 1.5%. Conclusion(s): Implementation of a universal HCV screening EHR alert was followed by a large increase in absolute screens and screening rates in the outpatient setting, despite the concurrent onset of the COVID-19 pandemic. These findings support that such an alert could play a crucial role in identification and subsequent elimination of HCV. Females, Black race and Medicaid patients were screened at higher rates, suggesting possible bias toward certain groups. Targeted testing in addition to universal screening remains a need despite much higher screening rates -expectedly, the proportion screened decreased, however the absolute number of HCV positive individuals decreased over time (data not shown). Our findings suggest that an EHR alert for universal screening could play a crucial role as the first step in identification and then elimination of HCV.

4.
Research and Practice in Thrombosis and Haemostasis Conference ; 6(Supplement 1), 2022.
Article in English | EMBASE | ID: covidwho-2128214

ABSTRACT

Background: Short-term cardiopulmonary extracorporeal life supports (ECLS) are invasive devices whose use has increased exponentially during the COVID-19 pandemic. Major bleeding is a main cause of morbi-mortality in ECLS patients and acquired von Willebrand disease (aVWD) could justify this complication. Aim(s): We aim at investigating the primary hemostasis alterations profile in ECLS patients, and to propose a potential treatment if bleeding. Method(s): Patients in ECLS at our center since June 2021 were included (n = 25). Primary hemostasis was evaluated by: Von Willebrand Factor antigen (VWF:Ag) and activity (VWF:GPIbM) measurement (immunoturbidimetry), VWF multimeric analysis (agarose-gels and immunoblotting), platelet function analysis (PFA-200), and platelet activation (CD62P and CD63 expression by flow cytometry). Studies were performed 24 h after implant, each 7 days, and in the first week after ECLS extraction. T-TAS was used for hemostasis analysis in samples from bleeding patients, before and after in vitro addition of purified VWF. This study was approved by the Hospital Clinic's Ethics Committee (HCB/2021/0200). Result(s): After 24 h of ECLS implant, increased VWF:Ag levels and prolonged PFA occlusion times. In 60% of patients, altered VWF:GPIbM/VWF:Ag ratio ( < 0.7) and loss of VWF high molecular weight multimers (HMWM) were observed. CD62P expression was slightly higher in ECLS patients platelets than in controls (MFI+/-SD of 4.34 +/- 2.2 vs. 3.27 +/- 0.6, respectively;p = 0.3). Early after ECLS extraction, there was normalization of the VWF multimeric profile and PFA values. Interestingly, in samples from bleeding patients, addition of purified VWF reduced significantly the T-TAS occlusion times (776 s+/-207 s vs. 1161 s+/-251 s, Mean+/-SD, post vs. pre, respectively;p = 0.033). Conclusion(s): ECLS caused primary hemostasis alterations, leading to aVWD and platelet activation, solved early after support removal. Hemostatic efficiency in ECLS bleeding patients, with lack of HMWM, was corrected in vitro by providing functional purified VWF. (Figure Presented).

5.
NeuroQuantology ; 20(13):2194-2202, 2022.
Article in English | EMBASE | ID: covidwho-2145494

ABSTRACT

The measures adopted worldwide by COVID-19 were mainly focused on social distancing. However, these measures affected the physical preparation of the members of the Ecuadorian Army. This research aimed to analyze the incidence of high intensity intervallic training in military personnel who were in confinement through a quasi-experimental study applying a virtual training plan to improve physical condition. For this purpose, VO2 max (maximum oxygen consumption that the organism can absorb), CORE resistance strength (abdominal, lumbar, pelvic and gluteal muscles) and upper body resistance strength were evaluated. The results were statistically analyzed through the Wilcoxon signed-rank test, obtaining significant differences that allowed concluding that the virtual training plan had a positive impact on the physical condition of the military personnel and that it constitutes an effective alternative for the physical preparation of members of the Army in the context that is currently being experienced due to the pandemic. Copyright © 2022, Anka Publishers. All rights reserved.

6.
European Psychiatry ; 64(Supplement 1):S270, 2021.
Article in English | EMBASE | ID: covidwho-2139959

ABSTRACT

Introduction: Pregnancy is a special risk factor for suicide attempts among females (Andrew E. Czeizel et al. 2011). Situational factors such as the novel coronavirus (COVID-19) have also been reported to impact on individual's mental health. Objective(s): Examine the effect of COVID-19 and its association with mental health and attempt suicide risk in pregnant population. Method(s): Across-sectional study that includes 113 pregnantwomen from Spain, through an anonymous, voluntary and multiple response type online survey which included questions about socio demographic aspects, COVID-19's aspects and mental health. Result(s): Of the 112 pregnant patients surveyed, only 2 reported suicidal ideation. The age of the respondents was 32 and 33 years, both of whom were in the 2nd trimester of pregnancy. Both report that it was the first pregnancy and affirm a worsening of their economic situation since the beginning of the COVID-19 pandemic. One of them did not have a partner / marriage and was living with a relative, in turn this respondent was unemployed. Both responded that they were always worried about the possible outcome of the COVID-19 pandemic and that their fears had increased, being difficult to control and let them pass. It is very relevant that both agree that they never felt that the professionals who carried out the pregnancy controls asked or inquired about their current state of mental health. Conclusion(s): Antepartum suicidal ideation is an important and common complication of pregnancy, specially in COVID-19's times, healthcare professionalswho follow pregnancy should detect high-risk suicidal patients and be able to carry out a suicide prevention program.

7.
Medicina intensiva ; 2022.
Article in English | EuropePMC | ID: covidwho-2092460

ABSTRACT

Objective To evaluate the rate of thrombosis, bleeding and mortality comparing anticoagulant doses in critically ill COVID-19 patients. Design Retrospective observational and analytical cohort study. Setting COVID-19 patients admitted to the intensive care unit of a tertiary hospital between March and April 2020. Patients 201 critically ill COVID-19 patients were included. Patients were categorized into three groups according to the highest anticoagulant dose received during hospitalization: prophylactic, intermediate and therapeutic. Interventions The incidence of venous thromboembolism (VTE), bleeding and mortality was compared between groups. We performed two logistic multivariable regressions to test the association between VTE and bleeding and the anticoagulant regimen. Main variables of interest VTE, bleeding and mortality. Results 78 patients received prophylactic, 94 intermediate and 29 therapeutic doses. No differences in VTE and mortality were found, while bleeding events were more frequent in the therapeutic (31%) and intermediate (15%) dose group than in the prophylactic group (5%) (p < 0.001 and p < 0.05 respectively). The anticoagulant dose was the strongest determinant for bleeding (odds ratio 2.4, 95% confidence interval 1.26–4.58, p = 0.008) but had no impact on VTE. Conclusions Intermediate and therapeutic doses appear to have a higher risk of bleeding without a decrease of VTE events and mortality in critically ill COVID-19 patients.

9.
Medicina Intensiva (English Edition) ; 2022.
Article in English | ScienceDirect | ID: covidwho-2086553

ABSTRACT

Objective To evaluate the rate of thrombosis, bleeding and mortality comparing anticoagulant doses in critically ill COVID-19 patients. Design Retrospective observational and analytical cohort study. Setting COVID-19 patients admitted to the intensive care unit of a tertiary hospital between March and April 2020. Patients 201 critically ill COVID-19 patients were included. Patients were categorized into three groups according to the highest anticoagulant dose received during hospitalization: prophylactic, intermediate and therapeutic. Interventions The incidence of venous thromboembolism (VTE), bleeding and mortality was compared between groups. We performed two logistic multivariable regressions to test the association between VTE and bleeding and the anticoagulant regimen. Main variables of interest VTE, bleeding and mortality. Results 78 patients received prophylactic, 94 intermediate and 29 therapeutic doses. No differences in VTE and mortality were found, while bleeding events were more frequent in the therapeutic (31%) and intermediate (15%) dose group than in the prophylactic group (5%) (p<0.001 and p<0.05 respectively). The anticoagulant dose was the strongest determinant for bleeding (odds ratio 2.4, 95% confidence interval 1.26–4.58, p=0.008) but had no impact on VTE. Conclusions Intermediate and therapeutic doses appear to have a higher risk of bleeding without a decrease of VTE events and mortality in critically ill COVID-19 patients. Resumen Objetivo Evaluar la incidencia de eventos trombóticos, sangrado y mortalidad comparando diferentes regímenes de anticoagulación en pacientes ingresados en unidades de Cuidados Intensivos (UCI) por COVID-19. Diseño Estudio de cohortes retrospectivo observacional y analítico. Ámbito Pacientes con COVID-19 ingresados en una UCI de un hospital terciario entre marzo y abril del 2020. Pacientes Se incluyó a un total de 201 pacientes de UCI ingresados por COVID-19. Los pacientes se categorizaron en 3 grupos en función de la dosis de anticoagulación más alta recibida durante el ingreso: profiláctica, intermedia y terapéutica. Intervenciones Se comparó la incidencia de eventos trombóticos, hemorragia y mortalidad entre los grupos. Se realizaron 2 regresiones logísticas multivariables para comprobar la asociación entre los eventos trombóticos y el sangrado con el régimen anticoagulante. Principales variables de interés Eventos trombóticos, sangrado y mortalidad. Resultados De los pacientes incluidos, 78 recibieron dosis profilácticas, 94 intermedias y 29 terapéuticas. No se encontraron diferencias en los eventos trombóticos y la mortalidad entre grupos, mientras que los sangrados fueron más frecuentes en el grupo de dosis terapéutica (31%) e intermedia (15%) que en el grupo de dosis profiláctica (5%) (p <0,001 y p <0,05, respectivamente). El régimen anticoagulante fue el mayor determinante de sangrado (odds ratio 2,4;, intervalo de confianza del 95%, 1,26-4,58;p=0,008) pero no tuvo ningún impacto en los eventos trombóticos. Conclusiones Las dosis intermedias y terapéuticas parecen tener un mayor riesgo de sangrado sin una disminución de los eventos trombóticos ni la mortalidad en pacientes de UCI con COVID-19.

10.
European psychiatry : the journal of the Association of European Psychiatrists ; 64(Suppl 1):S270-S270, 2021.
Article in English | EuropePMC | ID: covidwho-2073810

ABSTRACT

Introduction Pregnancy is a special risk factor for suicide attempts among females (Andrew E. Czeizel et al. 2011). Situational factors such as the novel coronavirus (COVID-19) have also been reported to impact on individual’s mental health. Objectives Examine the effect of COVID-19 and its association with mental health and attempt suicide risk in pregnant population. Methods A cross-sectional study that includes 113 pregnant women from Spain, through an anonymous, voluntary and multiple response type online survey which included questions about socio demographic aspects, COVID-19’s aspects and mental health. Results Of the 112 pregnant patients surveyed, only 2 reported suicidal ideation. The age of the respondents was 32 and 33 years, both of whom were in the 2nd trimester of pregnancy. Both report that it was the first pregnancy and affirm a worsening of their economic situation since the beginning of the COVID-19 pandemic. One of them did not have a partner / marriage and was living with a relative, in turn this respondent was unemployed. Both responded that they were “always” worried about the possible outcome of the COVID-19 pandemic and that their fears had increased, being difficult to control and let them pass. It is very relevant that both agree that they “never” felt that the professionals who carried out the pregnancy controls asked or inquired about their current state of mental health. Conclusions Antepartum suicidal ideation is an important and common complication of pregnancy, specially in COVID-19’s times, healthcare professionals who follow pregnancy should detect high-risk suicidal patients and be able to carry out a suicide prevention program.

11.
European psychiatry : the journal of the Association of European Psychiatrists ; 64(Suppl 1):S269-S270, 2021.
Article in English | EuropePMC | ID: covidwho-2073809

ABSTRACT

Introduction The new coronavirus (COVID-19) is being a threat to global health. Pregnancy is considered a state of vulnerability to mental health and can be even greater if they are facing the current pandemia. Objectives Within this framework, we wanted to inquire about the state of mental health, and more specifically, about depression, during pregnancy during pandemia COVID-19 and their opinion of the health team∙s professionals that controls pregnancy and how they are involved in the assessment of their mental health status. Also know her fears and uncertainties about the virus and its possible consequences (complications during pregnancy, childbirth or confinement at home, possible contact with COVID-19 positive patients). Methods A cross-sectional study was carried out that includes 73 pregnant women from Spain, during September 2020, through an anonymous, voluntary and multiple response type online survey which included questions about socio demographic aspects and the Beck Depression Inventory. Results The average age was 32 years. 90.41% were with a partner or married. The results of Beck’s questionnaire: 24.65% have moderate/severe depression. 25.65% had or had thought about consulting a mental health professional, 90.41% considered that professionals had not asked about their mental health during pregnancy. 98.89% reported fear of becoming infected and having to confine themselves at home and 97.26% reported fear of get COVID and affect the health of the unborn baby. Conclusions COVID-19 represents a huge challenge for pregnant women’s mental health. The Development and implementation of mental health service, skilled and aware of this area is crucial, for this vulnerable population.

12.
Lecture Notes in Networks and Systems ; 456:581-602, 2022.
Article in English | Scopus | ID: covidwho-2047997

ABSTRACT

The COVID-19 emergency lockdown in 2020 presented an unprecedented challenge that brought technology to the foreground. This chapter discusses the role of technology in language learning at higher education in the aftermath of the abrupt shift to emergency remote teaching due to the pandemic crisis. The chapter briefly introduces the area of language learning, including current trends in pedagogical approaches, focus points and learning objectives as well as the state of the art in computer-assisted language learning. Thereafter, three different but complementary strands for digital tools in language learning at higher education are discussed: digital tools as communication channels, as channels for delivering instruction and as ‘cognitive partners’. We argue that language education can advance the use of technologies in education in general and the acquisition of twenty-first century skills by higher education students, but we also discuss the need of redefining what it means to be a proficient speaker of a language in light of the numerous tools available. © 2022, The Author(s), under exclusive license to Springer Nature Switzerland AG.

13.
Medicina-Buenos Aires ; 82(3):463-464, 2022.
Article in Spanish | Web of Science | ID: covidwho-2030823
15.
Clinical and Translational Biophotonics, Translational 2022 ; 2022.
Article in English | Scopus | ID: covidwho-2011155

ABSTRACT

HEMOCOVID-19 is a multi-center trial aiming to assess the microvascular and endothelial health of severe COVID-19 patients in the intensive care using near-infrared spectroscopy. Here, we present the preliminary results, showing that peripheral microcirculatory alterations are associated with the severity of acute respiratory distress syndrome. © 2022 The Author(s).

16.
Annals of the Rheumatic Diseases ; 81:1665-1666, 2022.
Article in English | EMBASE | ID: covidwho-2008843

ABSTRACT

Background: Currently there is little information on the efficacy and safety of SARS-CoV-2 vaccination in patients with immune-mediated diseases and/or under immunosuppressive treatment in our country, where different types of vaccines and mix regimens are used. For this reason, the Argentine Society of Rheumatology (SAR) with the Argentine Society of Psoriasis (SOARPSO) set out to develop a national register of patients with rheumatic and immune-mediated infammatory diseases (IMIDs) who have received a SARS-CoV-2 vaccine in order to assess their efficacy and safety in this population. Objectives: To assess SARS-CoV-2 vaccine efficacy and safety in patients with rheumatic and IMIDs. Methods: SAR-CoVAC is a national, multicenter and observational registry. Adult patients with a diagnosis of rheumatic or IMIDs who have been vaccinated for SARS-CoV-2 were consecutively included between June 1st and September 17th, 2021. Sociodemographic data, comorbidities, underlying rheumatic or IMIDs, treatments received and their modifcation prior to vaccination and history of SARS-CoV-2 infection were recorded. In addition, the date and place of vaccination, type of vaccine applied, scheme and indication will be registered. Finally, adverse events (AE), as well as SARS-CoV-2 infection after the application of the vaccine were documented Results: A total of 1234 patients were included, 79% were female, with a mean age of 57.8 (SD 14.1) years. The most frequent diseases were rheumatoid arthritis (41.2%), osteoarthritis (14.5%), psoriasis (12.7%) and spondy-loarthritis (12.3%). Most of them were in remission (28.5%) and low disease activity (41.4%). At the time of vaccination, 21% were receiving glucocorti-coid treatment, 35.7% methotrexate, 29.7% biological (b) Disease Modifying Anti-Rheumatic Drugs (DMARDs) and 5.4% JAK inhibitors. Before vaccine application 16.9% had had a SARS-CoV-2 infection. Regarding the frst dose of the vaccine, the most of the patients (51.1%) received Gam-COV-ID-Vac, followed by ChAdOx1 nCoV-19 (32.8%) and BBIBP-CorV (14.5%). In a lesser proportion, BNT162b2 (0.6%), Ad26.COV2.S (0.2%) and Coro-naVac (0.2%) vaccines were used. Almost half of them (48.8%) completed the scheme, 12.5% were mix regimenes, the most frequent being Gam-COVID-Vac/mRNA-1273. The median time between doses was 51days (IQR 53). More than a quarter (25.9%) of the patients reported at least one AE after the frst dose and 15.9% after the second. The fu-like syndrome and local hypersensitivity were the most frequent manifestations. There was one case of mild anaphylaxis. No patient was hospitalized. Altogether, the incidence of AE was 246.5 events/1000 doses. BBIBP-CorV presented signifcantly lower incidence of AE in comparison with the other types of vaccines. (118.5 events/1000 doses, p<0.002 in all cases) Regarding efficacy, 63 events of SARS-CoV-2 infection were reported after vaccination, 19% occurred before 14 days post-vaccination, 57.1% after the frst dose (>14 days) and 23.8% after the second. In most cases (85.9%) the infection was asymptomatic or had an outpatient course and 2 died due to COVID-19. Conclusion: In this national cohort of patients with rheumatic and IMIDs vaccinated for SARS-CoV-2, the most widely used vaccines were Gam-COVID-Vac and ChAdOx1 nCoV-19, approximately half completed the schedule and in most cases homologously. A quarter of the patients presented some AE, while 5.1% presented SARS-CoV-2 infection after vaccination, in most cases mild.

17.
Annals of the Rheumatic Diseases ; 81:929, 2022.
Article in English | EMBASE | ID: covidwho-2008840

ABSTRACT

Background: Patients with rheumatic diseases (RD) have been excluded from SARS-CoV-2 vaccine trials, though data appear to show safety and efficacy, mostly evidence remains in mRNA vaccines. In our country, adenovirus-vector, inactivated and heterologous scheme vaccines are frequently used. Objectives: To describe the safety of SARS-CoV-2 vaccines in patients with RD from the national registry SAR-CoVAC and to assess sociodemographic and clinical factors associated to AE and disease fares after vaccination. Methods: Adult patients with RD who have been vaccinated for SARS-CoV-2 from de Argentine Society of Rheumatology Vaccine Registry (SAR-CoVAC) were consecutively included between June 1st and December 21st, 2021, This is a national multicentric observational registry that includes patients that have received at least one dose of any SARS-CoV-2 available vaccines in Argentina. Data is voluntarily collected by the treating physician. Naranjo scale was use to assess the association between the AE and vaccination. Homologous and heterologous schedules were defned according to whether both vaccines received were the same or different, respectively. Descriptive statics, Chi2 test, Fischer test, T test, ANOVA and multivariate regression logistic model were used. Results: A total of 1679 patients, with 2795 SARS-CoV-2 vaccine doses were included. Vaccines more frequently used were: Gam-COVID-Vac (1227 doses, 44%), ChAdOx1 nCov-19 (872 doses, 31%), BBIBP-CorV (482 doses, 17%) and mRAN-1273 (172 doses, 6%). Altogether, 510 EA were experienced by 449 (27%) patients. Pseudo-fu syndrome was the most frequent (11%), followed by injection site reaction (7%). They were signifcantly more frequent after the frst dose in comparison to the second one (13% vs 7% and 9% vs 5%, respectively, p<0.001 in both cases). All were mild or moderate and no patient was hospitalized due to an AE. One case of moderate anaphylaxis was reported by a patient who received Gam-COVID-Vac. No cases of vaccine-induced thrombotic thrombocytopenia were observed. There were 25 disease fares reported, 17 (68%) cases of arthritis. Among patients with two doses, those with heterol-ogous schedule presented AE more frequent after the second dose (39% vs 17%).Total incidence of EA was 182.5 events/10 00 doses, it was signifcantly lower for BBIBP-CorV (105.9 events/1000 dosis, p<0.002 for all cases). The higher incidence of AE was observed for mRAN-1273 (261.6 events/1000 doses) and ChAdOx1 nCov-19 (232.8 events/1000 doses). Patients with AE were younger [mean 55 years (SD 14) vs 59 years (SD 14), p <0.010], not Caucasian ethnicity [48% vs 35%, p<0.001], had higher education level [mean 13.8 years (SD 4) vs 11.9 years (SD 5), p<0.001], were more frequently employed [54% vs 44%, p<0.001], lived mostly in urban area [99% vs 95% p <0.001, had more frequently dyslipidemia [38% vs 28% p 0.012], and less frequently arterial hypertension [49% vs 65%, p<0.001]. Systemic lupus erythematosus [11% vs 7%, p=0.039] and Sjögren syndrome [6% vs 1.8%, p<0.001] were more frequent among them, while non infammatory diseases were less prevalent [19% vs 31%, p<0.001]. They were taking steroids [24 vs 18%, p=0.007], antimalarials [17% vs 10%, p<0.001] and methotrexate [41% vs 31%, p <0.001] more frequently. In the multivariable analysis, mRAN-1273 and ChAdOx1 nCov-19 were associated with AE, while BBIBP-CorV with lower probability of having one. (Figure 1) Conclusion: The incidence of AE was 1825 events/1000 doses, were signif-cantly higher for mRAN-1273 and ChAdOx1 nCov-19 and lower for BBIBP-CorV. Most common AE was pseudo-fu syndrome. Female sex, being younger, higher education level, ChAdOx1 nCov-19 and mRAN-1273 vaccines, the use of meth-otrexate and antimalarials were related of EA in patients with RD.

18.
Pediatrics ; 149, 2022.
Article in English | EMBASE | ID: covidwho-2003402

ABSTRACT

Background: Food insecurity has long been established as a social determinant of health. Food insecurity in children is correlated with adverse health outcomes including poor overall health, obesity, asthma, allergies, anxiety and depression. Traditional interventions for food insecurity in the pediatric primary care setting have included referral to food banks, food vouchers and assistance programs. Limited research has been done examining the impact of meal delivery or of the feasibility of integrating food assistance directly into the pediatric practice. The objective of this pilot study is to determine if a medical home centered meal delivery program is acceptable, feasible and effective in reducing food insecurity and stress in families with children ages 0-5. Methods: The Division of Community Pediatrics (DCP) provides healthcare to vulnerable children in an urban area. DCP partnered with Share Our Strength's No Kid Hungry, and the Power of 10, a restaurant industry non-profit, to design and implement a pilot program to address food insecurity for families with young children during the COVID-19 pandemic. Ready to heat and serve healthy meals were delivered to the household twice a week to provide one meal per day per family member for 10 weeks. Surveys were conducted before and after receipt of 10 weeks of meal delivery during the pandemic among an adult caregiver. Survey questions were adapted from existing survey tools that examine meal delivery program implementation effectiveness, program acceptability, food insecurity and caregiver stress. Results: 43 families with at least one child age 0-5 enrolled and received meals. The majority (83%) stayed in the program until the conclusion. 31 families completed both the pre-test and the post-test. The average household size of participants was 5.6 members with an average of 2 children under age 5. Most (84%) participants were already receiving food assistance like WIC and/or SNAP benefits. The number of families who experienced food insecurity decreased with program participation (Table 1). Satisfaction and acceptability with the program was high (Table 2). Most (77.4%) said they and their children ate more fruits and vegetables than normal. Of those worried about food before the intervention, 66.7% were no longer worried at the end of the program (p=0.0001). Of those who ran out of food before the intervention, 71% reported no longer running out of food at the end of the intervention (p=0.0001). Conclusion: This innovative pilot program demonstrated that meal delivery through the primary care setting is feasible and effective in reducing food insecurity. It improved the quality of food consumed. Participants were satisfied with the program and there was a high retention rate. There was less reported worry about food running out by the conclusion of the program.

19.
IEEE Access ; : 1-1, 2022.
Article in English | Scopus | ID: covidwho-1992570

ABSTRACT

Fueled by advances in multi-party communications, increasingly mature immersive technologies being adopted, and the COVID-19 pandemic, a new wave of social virtual reality (VR) platforms have emerged to support socialization, interaction, and collaboration among multiple remote users who are integrated into shared virtual environments. Social VR aims to increase levels of (co-)presence and interaction quality by overcoming the limitations of 2D windowed representations in traditional multi-party video conferencing tools, although most existing solutions rely on 3D avatars to represent users. This article presents a social VR platform that supports real-time volumetric holographic representations of users that are based on point clouds captured by off-the-shelf RGB-D sensors, and it analyzes the platform’s potential for conducting interactive holomeetings (i.e., holoconferencing scenarios). This work evaluates such a platform’s performance and readiness for conducting meetings with up to four users, and it provides insights into aspects of the user experience when using single-camera and low-cost capture systems in scenarios with both frontal and side viewpoints. Overall, the obtained results confirm the platform’s maturity and the potential of holographic communications for conducting interactive multi-party meetings, even when using low-cost systems and single-camera capture systems in scenarios where users are sitting or have a limited translational movement along the X, Y, and Z axes within the 3D virtual environment (commonly known as 3 Degrees of Freedom plus, 3DoF+). Author

20.
Advances in Laboratory Medicine ; 3(2):126-133, 2022.
Article in English | Scopus | ID: covidwho-1951607

ABSTRACT

Introduction: Abnormal liver biochemistry is not a rare finding in the context of SARS-CoV-2 infection, regardless of patients having pre-existing chronic disease or not Content: This review examines the current body of knowledge on the relationship between COVID-19 and liver injury, which is frequently found in this setting Summary: Although the pathogenesis of liver injury is not fully understood, it has been suggested to be the result of a combination of multiple factors. These include direct injury caused by the virus, immune system hyperactivation, ischemic and drug-induced injury. The prognostic valor of these alterations is also the subject of intense research. Due to their potential impact, these alterations require proper management and treatment, especially in patients with chronic liver disease or liver transplant recipients. Outlook: Some aspects associated with liver injury during COVID-19, especially in severe presentations, are not well understood. Studies assessing the clinical impact of COVID-19 on the healthy or diseased liver may help adjust treatment and immunization guidelines to the profile of the patient. © 2022 Sergio Salgüero Fernández et al., published by De Gruyter, Berlin/Boston.

SELECTION OF CITATIONS
SEARCH DETAIL